Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential microRNA expression in the peripheral blood from human patients with COVID‐19
Caixia Li, Xiao Hu, Leilei Li, et al.
Journal of Clinical Laboratory Analysis (2020) Vol. 34, Iss. 10
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 475-495
Open Access | Times Cited: 253
The miRNA: a small but powerful RNA for COVID-19
Song Zhang, Kuerbannisha Amahong, Xiuna Sun, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 2, pp. 1137-1149
Open Access | Times Cited: 136
Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients
David de Gonzalo‐Calvo, Iván D. Benítez, Lucía Pinilla, et al.
Translational research (2021) Vol. 236, pp. 147-159
Open Access | Times Cited: 123
miRNAs; a novel strategy for the treatment of COVID‐19
Ying Hao, Mohsen Ebrahimi, Mona Keivan, et al.
Cell Biology International (2021) Vol. 45, Iss. 10, pp. 2045-2053
Open Access | Times Cited: 78
The Role of miRNAs in COVID-19 Disease
Mona Fani, Milad Zandi, Saeedeh Ebrahimi, et al.
Future Virology (2021) Vol. 16, Iss. 4, pp. 301-306
Open Access | Times Cited: 69
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality
Asier Fernández-Pato, Ana Virseda‐Berdices, Salvador Resino, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 676-688
Open Access | Times Cited: 67
SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes
Paulina Pawlica, Therese A. Yario, Sylvia S. White, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 66
A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood
Yingping Wu, Tiejun Zhao, Riqiang Deng, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 61
Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19)
Mohammad Fayyad‐Kazan, Rawan Makki, Najwa Skafi, et al.
Infection Genetics and Evolution (2021) Vol. 94, pp. 105020-105020
Open Access | Times Cited: 56
Role of miRNA dysregulation in sepsis
Amanda Formosa, Paul J. Turgeon, Claúdia C. dos Santos
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 42
MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression
Hatem Mohamed, Aya Eid Abdelkafy, Rasha M. M. Khairy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease
Ruth Drury, Susana Camara, Irina Chelysheva, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
A Survey of Deep Learning for Detecting miRNA- Disease Associations: Databases, Computational Methods, Challenges, and Future Directions
Nan Sheng, Xuping Xie, Yan Wang, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2024) Vol. 21, Iss. 3, pp. 328-347
Closed Access | Times Cited: 9
RNA–RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection
Song Zhang, Kuerbannisha Amahong, Chenyang Zhang, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 55
Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
Antonio Recchiuti, Sara Patruno, Domenico Mattoscio, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Open Access | Times Cited: 50
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection
Riham Abdel‐Hamid Haroun, Waleed H. Osman, Rasha E. Amin, et al.
Pathology (2021) Vol. 54, Iss. 1, pp. 104-110
Open Access | Times Cited: 50
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review
Rafael Marchi, Bruna M. Sugita, Ariana Centa, et al.
Infection Genetics and Evolution (2021) Vol. 91, pp. 104832-104832
Open Access | Times Cited: 48
MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer
Jacek Kabziński, Monika Maczynska, Ireneusz Majsterek
Biomolecules (2021) Vol. 11, Iss. 6, pp. 844-844
Open Access | Times Cited: 46
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene
Shaw M. Akula, Paul Bolin, Paul Cook
RNA Biology (2021) Vol. 19, Iss. 1, pp. 1-11
Open Access | Times Cited: 46
The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization
Reza Keikha, Seyed Mohammad Hashemi‐Shahri, Ali Jebali
European journal of medical research (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 44
Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis
Hadar Medini, Amit Zirman, Dan Mishmar
iScience (2021) Vol. 24, Iss. 12, pp. 103471-103471
Open Access | Times Cited: 43
Mechanisms contributing to adverse outcomes of COVID-19 in obesity
Manu Sudhakar, Sofi Beaula Winfred, Gowri Meiyazhagan, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 4, pp. 1155-1193
Open Access | Times Cited: 38
miR-146a, miR-221, and miR-155 are Involved in Inflammatory Immune Response in Severe COVID-19 Patients
Noemí Gaytán-Pacheco, Alejandro Ibáñez-Salazar, Ana Sofía Herrera-Van Oostdam, et al.
Diagnostics (2022) Vol. 13, Iss. 1, pp. 133-133
Open Access | Times Cited: 37
Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach
Lu Lu, Leping Liu, Rong Gui, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Circulating microRNAs as emerging regulators of COVID-19
Yulong Liang, Dan Fang, Xiaojun Gao, et al.
Theranostics (2022) Vol. 13, Iss. 1, pp. 125-147
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top